(PDF) Neutralizing Antibody and Anti-Retroviral Drug

Neutralizing Antibody and Anti-Retroviral Drug Sensitivities of HIV-1 Isolates Resistant to Small Molecule CCR5 Inhibitors

Virology - United States

doi 10.1016/j.virol.2008.04.032

Full Text

Abstract

Available in full text

Categories

Date

August 1, 2008

Authors

Thomas J. Ketas

Elizabeth Michael

Publisher

Elsevier BV

Related search

HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug

Journal of Virology

English

Development of Tetravalent, Bispecific CCR5 Antibodies With Antiviral Activity Against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

From Oncogene to Drug: Development of Small Molecule Tyrosine Kinase Inhibitors as Anti-Tumor and Anti-Angiogenic Agents

Cancer Research

Molecular Biology

English

Drug–drug Interactions Between Anti-Retroviral Therapies and Drugs of Abuse in HIV Systems

Expert Opinion on Drug Metabolism and Toxicology

English

Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity

Scandinavian Journal of Immunology

English

HIV-1 Escape From a Small Molecule, CCR5-specific Entry Inhibitor Does Not Involve CXCR4 Use

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors

Molecular Biology

Biological Sciences

English

Lack of Synergy for Inhibitors Targeting a Multi-Drug Resistant Hiv-1 Protease

English